New drug OBI-3424 designated an ‘Orphan Drug’ to treat acute lymphoblastic leukaemia

19/10/2018


A drug called OBI-3424 has been designated an Orphan Drug by the U.S. Food and Drug Administration (FDA) to treat acute lymphoblastic leukaemia, based predominantly on research carried out by our Leukaemia Biology Program.

'

Dr Toby Trahair – childhood cancer researcher and fundraiser with Tour de Cure

26/04/2018


One of our Clinical Research Fellows, Dr Toby Trahair, is taking part in the Tour de Cure Signature Tour 2018 which starts on Friday 27th April, raising money for cancer research by cycling 1110km from Mackay to Cairns.

'

My daughter’s cancer journey

23/04/2018


Mackenzie was diagnosed with Acute Lymphoblastic Leukaemia (ALL) at just 9 years old. Her mum, Errin, has recently spoken about Mackenzie’s journey.

'

How specific DNA ‘microdeletions’ help predict leukaemia relapse

11/12/2017


If doctors can reliably tell which children are most likely to get their leukaemia back, they can offer more intensive treatment options to prevent it.

'Associate Professor Rosemary Sutton

We made great strides with childhood leukaemia – we can do the same for brain cancer

10/11/2017


Brain cancers are the leading disease-related cause of death in Australian children. In this article, first published in The Conversation, A/Prof David Ziegler explains what we can learn from improving childhood leukaemia survival.

'MRI brain scan (image: iStock)

Potential leukaemia drug excites international researchers

02/11/2017


We presented exciting results from preclinical drug testing at a cancer conference this week in the US.

'Prof Richard Lock (second from left) at conference

Awareness Wednesday: testing our results

13/09/2017


In this second post in our series for Childhood Cancer Awareness month, see how we apply the basics about childhood cancer to search for better treatments.

'Working at fume hood in lab

Sights set on an aggressive childhood leukaemia

17/07/2017


Our latest research is providing ammunition to target the rare but aggressive MLLr leukaemia subtype.

'Mother holding a baby's hand during treatment

New leukaemia subtype found by DNA test

31/03/2017


A previously unknown subgroup of high-risk leukaemia in children has been revealed with a new, more accurate DNA test.

'

Glowing report: firefly gene shows hidden leukaemia cells

16/02/2017


A test that makes drug-resistant leukaemia cells glow could reveal a brighter future for developing new leukaemia therapies.

'Dr Luke Jones with bioluminescent images